Walleye Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.1M Buy
1,070,486
+596,980
+126% +$15.9M 0.13% 95
2025
Q4
$11.8M Sell
473,506
-746,663
-61% -$18.8M 0.04% 546
2025
Q3
$31.1M Buy
1,220,169
+460,173
+61% +$11.4M 0.12% 128
2025
Q2
$18.4M Buy
759,996
+523,541
+221% +$12.2M 0.07% 266
2025
Q1
$5.99M Sell
236,455
-967,046
-80% -$25.3M 0.03% 682
2024
Q4
$31.9M Buy
1,203,501
+371,542
+45% +$10.1M 0.08% 198
2024
Q3
$24.1M Sell
831,959
-31,479
-4% -$918K 0.05% 274
2024
Q2
$24.2M Buy
863,438
+284,003
+49% +$7.82M 0.04% 291
2024
Q1
$16.1M Sell
579,435
-20,325
-3% -$564K 0.03% 542
2023
Q4
$17.3M Buy
599,760
+409,524
+215% +$12.4M 0.04% 398
2023
Q3
$6.31M Buy
+190,236
New +$6.73M 0.02% 873
2020
Q3
Sell
-7,188
Closed -$223K 935
2020
Q2
$223K Buy
+7,188
New +$244K 0.05% 401
2019
Q4
Sell
-349
Closed -$12K 2151
2019
Q3
$12K Buy
+349
New +$12.7K ﹤0.01% 1765

Other funds holding PFE

Walleye Capital's PFE Position: Q1 2026 in Review

Walleye Capital increased its Pfizer (PFE) stake by 126% in Q1 2026, buying an estimated $15.9M and bringing the position to 1,070,486 shares worth $30.1M. The position accounts for 0.13% of the portfolio, ranked #95.

Walleye Capital first reported a position in PFE in Q3 2019 and has held it in 13 quarters since. The position peaked at $31.9M in Q4 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Walleye Capital held 1,070,486 shares of Pfizer worth $30.1M as of Q1 2026.
  • Walleye Capital bought 596,980 Pfizer shares in Q1 2026, an estimated $15.9M.
  • Pfizer made up 0.13% of Walleye Capital's portfolio in Q1 2026, its #95 holding.
  • Walleye Capital first reported a position in Pfizer in Q3 2019 and has held it in 13 quarters since.
  • Walleye Capital's Pfizer position peaked at $31.9M in Q4 2024.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.